Table 4.

Best overall response by Response Evaluation Criteria in Solid Tumors

Level 1A* (n = 4)
Level 1 (n = 18)
Level 2 (n = 13)
Level 3 (n = 6)
Total (N = 41)
No. patientsNo. patients (%)
Partial response04105 (12)
Stable disease41410533 (80)
    ≥6 mo492015 (37)
    <6 mo054211 (27)
    Unknown00437 (17)
Progressive disease00101 (2)
Other00112 (5)
  • * Patients with severe neutropenia in cycle 1 but without prophylactic G-CSF use.

  • Follow-up <6 mo and without disease progression.

  • Not enough data to establish response type.